Prof. Dr. med. Lorenz H. Trümper

Name Card

Staff Status
unigoe
 

1-58 of 58
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2022 | Journal Article | Research Paper | 
    ​ ​“SpezPat”- common advance directives versus disease-centred advance directives: a randomised controlled pilot study on the impact on physicians’ understanding of non-small cell lung cancer patients’ end-of-life decisions​
    Koenig, J. F. L.; Asendorf, T. ; Simon, A. ; Bleckmann, A. ; Trümper, L. ; Wulf, G. G.   & Overbeck, T. R. ​ (2022) 
    BMC Palliative Care, 21(1) art. 167​.​ DOI: https://doi.org/10.1186/s12904-022-01057-5 
    ​Details  DOI 
  • 2022 | Journal Article | Research Paper | 
    ​ ​Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective Analysis​
    Shumilov, E.; Aperdannier, L.; Schmidt, N.; Szuszies, C.; Neesse, A. ; Hoffknecht, P. & Khandanpour, C. et al.​ (2022) 
    Cancers, 14(15).​ DOI: https://doi.org/10.3390/cancers14153746 
    ​Details  DOI 
  • 2022 | Journal Article | 
    ​ ​Superresolution microscopy localizes endogenous Dvl2 to Wnt signaling-responsive biomolecular condensates​
    Schubert, A.; Voloshanenko, O.; Ragaller, F.; Gmach, P.; Kranz, D.; Scheeder, C. & Miersch, T. et al.​ (2022) 
    Proceedings of the National Academy of Sciences, 119(30) art. e2122476119​.​ DOI: https://doi.org/10.1073/pnas.2122476119 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​PCN62 Real-World Costs of FRONT-LINE Treatment for Peripheral T-Cell Lymphoma in France, Germany, and the United Kingdom​
    Ashaye, A.; Shah, R.; Corman, S.; Dalal, M.; Fox, C. & Trumper, L. ​ (2021) 
    Value in Health, 24 pp. S30​.​ DOI: https://doi.org/10.1016/j.jval.2021.04.154 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​The “Burkitt-like” immunophenotype and genotype is rarely encountered in diffuse large B cell lymphoma and high-grade B cell lymphoma, NOS​
    Hüttl, K. S.; Staiger, A. M.; Richter, J.; Ott, M. M.; Kalmbach, S.; Klapper, W. & Biesdorf, A.-S. et al.​ (2021) 
    Virchows Archiv,.​ DOI: https://doi.org/10.1007/s00428-021-03050-4 
    ​Details  DOI 
  • 2021 | Journal Article
    ​ ​Long-term survival of patients with mantle cell lymphoma after autologous haematopoietic stem-cell transplantation in first remission: a post-hoc analysis of an open-label, multicentre, randomised, phase 3 trial​
    Zoellner, A.-K.; Unterhalt, M.; Stilgenbauer, S.; Hübel, K.; Thieblemont, C.; Metzner, B. & Topp, M. et al.​ (2021) 
    The Lancet Haematology, 8(9) pp. e648​-e657​.​ DOI: https://doi.org/10.1016/S2352-3026(21)00195-2 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​A 70% cut-off for MYC protein expression in diffuse large B cell lymphoma identifies a high-risk group of patients​
    Ziepert, M.; Lazzi, S.; Santi, R.; Vergoni, F.; Granai, M.; Mancini, V. & Staiger, A. et al.​ (2020) 
    Haematologica, 105(11) pp. 2667​-2670​.​ DOI: https://doi.org/10.3324/haematol.2019.235556 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Dihydropyrimidine Dehydrogenase Testing prior to Treatment with 5-Fluorouracil, Capecitabine, and Tegafur: A Consensus Paper​
    Wörmann, B.; Bokemeyer, C.; Burmeister, T.; Köhne, C.-H.; Schwab, M.; Arnold, D. & Blohmer, J.-U. et al.​ (2020) 
    Oncology Research and Treatment, 43(11) pp. 628​-636​.​ DOI: https://doi.org/10.1159/000510258 
    ​Details  DOI 
  • 2020 | Journal Article
    ​ ​Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial​
    Wulf, G. G. ; Altmann, B.; Ziepert, M.; D’Amore, F.; Held, G.; Greil, R. & Tournilhac, O. et al.​ (2020) 
    Leukemia,.​ DOI: https://doi.org/10.1038/s41375-020-0838-5 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Radioimmunotherapy for mantle cell lymphoma: 5-year follow-up of 90 patients from the international RIT registry​
    Hohloch, K. ; Windemuth-Kieselbach, C.; Zinzani, P. L.; Cacchione, R.; Jurczak, W.; Suh, C. & Trümper, L.  et al.​ (2020) 
    Annals of Hematology, 99(5) pp. 1073​-1079​.​ DOI: https://doi.org/10.1007/s00277-020-03956-0 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Am individuellen Therapieergebnis orientierte Erstattungsverfahren in der Onkologie: ethische Implikationen am Beispiel der CAR-T-Zelltherapie​
    König, J.; Gerst, C.; Trümper, L. ; Wulf, G. G.   & Wiesemann, C. ​ (2020) 
    Ethik in der Medizin, 32(1) pp. 85​-92​.​ DOI: https://doi.org/10.1007/s00481-020-00565-3 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation​
    Bleckmann, A. ; Dierks, S.; Schildhaus, H.-U. ; Hellige, N.; Bacher, U. ; Trümper, L.   & Wulf, G. ​ (2020) 
    Annals of Hematology,.​ DOI: https://doi.org/10.1007/s00277-020-03974-y 
    ​Details  DOI 
  • 2020 | Journal Article | Research Paper | 
    ​ ​Low serum albumin is an independent risk factor in elderly patients with aggressive B‐cell lymphoma: Results from prospective trials of the German High‐Grade Non‐Hodgkin's Lymphoma Study Group​
    Høhloch, K. ; Ziepert, M.; Trümper, L. ; Buske, C.; Held, G.; Poeschel, V. & Chapuy, B.  et al.​ (2020) 
    eJHaem, 1(1) pp. 181​-187​.​ DOI: https://doi.org/10.1002/jha2.61 
    ​Details  DOI 
  • 2020 | Journal Article | 
    ​ ​Age-dependent increase of treatment-related mortality in older patients with aggressive B cell lymphoma: analysis of outcome, treatment feasibility, and toxicity in 1171 elderly patients with aggressive B cell lymphoma—data from phase II and III trials of the DSHNHL (German High-Grade Non-Hodgkin’s Lymphoma Study Group)​
    Zettl, F.; Ziepert, M.; Altmann, B.; Zeynalova, S.; Held, G.; Pöschel, V. & Hohloch, K.  et al.​ (2020) 
    Annals of Hematology, 100(4) pp. 1031​-1038​.​ DOI: https://doi.org/10.1007/s00277-020-04345-3 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Randomized Phase III Study of Alisertib or Investigator’s Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma​
    O’Connor, O. A.; Özcan, M.; Jacobsen, E. D.; Roncero, J. M.; Trotman, J.; Demeter, J. & Masszi, T. et al.​ (2019) 
    Journal of Clinical Oncology, 37(8) pp. 613​-623​.​ DOI: https://doi.org/10.1200/JCO.18.00899 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Effect of gloved hand disinfection on hand hygiene before infection-prone procedures on a stem cell ward​
    Fehling, P.; Hasenkamp, J. ; Unkel, S. ; Thalmann, I.; Hornig, S.; Trümper, L.   & Scheithauer, S. ​ (2019) 
    Journal of Hospital Infection, 103(3) pp. 321​-327​.​ DOI: https://doi.org/10.1016/j.jhin.2019.06.004 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​MDM4 Is Targeted by 1q Gain and Drives Disease in Burkitt Lymphoma​
    Hüllein, J.; Słabicki, M.; Rosolowski, M.; Jethwa, A.; Habringer, S.; Tomska, K. & Kurilov, R. et al.​ (2019) 
    Cancer Research, 79(12) pp. 3125​-3138​.​ DOI: https://doi.org/10.1158/0008-5472.CAN-18-3438 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​A novel lymphoma-associated macrophage interaction signature (LAMIS) provides robust risk prognostication in diffuse large B-cell lymphoma clinical trial cohorts of the DSHNHL​
    Staiger, A. M.; Altenbuchinger, M. ; Ziepert, M.; Kohler, C.; Horn, H.; Huttner, M. & Hüttl, K. S. et al.​ (2019) 
    Leukemia, 34(2) pp. 543​-552​.​ DOI: https://doi.org/10.1038/s41375-019-0573-y 
    ​Details  DOI 
  • 2019 | Journal Article | 
    ​ ​Non-Hodgkin-Lymphome​
    Trümper, L.   & Schmidberger, H.​ (2019) 
    Der Onkologe, 25(10) pp. 846​-848​.​ DOI: https://doi.org/10.1007/s00761-019-00654-z 
    ​Details  DOI 
  • 2019 | Journal Article
    ​ ​Critical evaluation of current molecular MRD strategies including NGS for the management of AML patients with multiple mutations​
    Shumilov, E.; Flach, J.; Joncourt, R.; Porret, N.; Wiedemann, G.; Angelillo‐Scherrer, A. & Trümper, L.  et al.​ (2019) 
    Hematological Oncology, 37(3) pp. 319​-322​.​ DOI: https://doi.org/10.1002/hon.2603 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Gene expression profiling reveals a close relationship between follicular lymphoma grade 3A and 3B, but distinct profiles of follicular lymphoma grade 1 and 2​
    Horn, H.; Kohler, C.; Witzig, R.; Kreuz, M.; Leich, E.; Klapper, W. & Hummel, M. et al.​ (2018) 
    Haematologica, 103(7) pp. 1182​-1190​.​ DOI: https://doi.org/10.3324/haematol.2017.181024 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology​
    Shumilov, E.; Flach, J.; Pabst, T.; Fiedler, M.; Angelillo-Scherrer, A.; Trümper, L.   & Joncourt, R. et al.​ (2018) 
    Critical Reviews in Oncology/Hematology, 126 pp. 64​-79​.​ DOI: https://doi.org/10.1016/j.critrevonc.2018.03.020 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Final Analysis of the Front-Line Phase III Randomized ACT-1 Trial in Younger Patients with Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated By Autologous Hematopoietic Stem Cell Transplant​
    d'Amore, F.; Leppä, S.; Silva, M. G. da; Relander, T.; Lauritzsen, G. F.; Brown, P. D. N. & Pezzutto, A. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 998​-998​.​ DOI: https://doi.org/10.1182/blood-2018-99-110429 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Allogeneic stem cell transplantation for patients with relapsed or refractory T-cell lymphoma: efficacy of lymphoma-directed conditioning against advanced disease​
    Wulf, G. ; Hasenkamp, J. ; Jung, W. ; Wilhelm, C.; Held, G.; Nickelsen, M. & Leha, A.  et al.​ (2018) 
    Bone Marrow Transplantation, 54(6) pp. 877​-884​.​ DOI: https://doi.org/10.1038/s41409-018-0360-9 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​The ECHELON-2 Trial: Results of a Randomized, Double-Blind, Active-Controlled Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in the Frontline Treatment of Patients with CD30+ Peripheral T-Cell Lymphomas​
    Horwitz, S. M.; O'Connor, O. A.; Pro, B.; Illidge, T. M.; Fanale, M. A.; Advani, R. H & Bartlett, N. L. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 997​-997​.​ DOI: https://doi.org/10.1182/blood-2018-99-110563 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​A New Stromal Signature Applicable to Formalin-Fixed Paraffin-Embedded Tissues Identifies Patients at Risk in Prospective Clinical Trials of the German High-Grade Non-Hodgkin Lymphoma Study Group​
    Staiger, A. M.; Altenbuchinger, M.; Ziepert, M.; Kohler, C.; Horn, H.; Huttner, M. & Huettl, K. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 343​-343​.​ DOI: https://doi.org/10.1182/blood-2018-99-112450 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Radiotherapy (RT) to bulky (B) and extralymphatic (E) disease in combination with 6xR-CHOP-14 or R-CHOP-21 in young good-prognosis DLBCL patients: Results of the 2x2 randomized UNFOLDER trial of the DSHNHL/GLA.​
    Pfreundschuh, M.; Murawski, N.; Ziepert, M.; Altmann, B.; Dreyling, M. H.; Borchmann, P. & Luminari, S. et al.​ (2018) 
    Journal of Clinical Oncology, 36(15_suppl) pp. 7574​-7574​.​ DOI: https://doi.org/10.1200/JCO.2018.36.15_suppl.7574 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Excellent Outcome of Young Patients (18-60 years) with Favourable-Prognosis Diffuse Large B-Cell Lymphoma (DLBCL) Treated with 4 Cycles CHOP Plus 6 Applications of Rituximab: Results of the 592 Patients of the Flyer Trial of the Dshnhl/GLA​
    Poeschel, V.; Held, G.; Ziepert, M.; Altmann, B.; Witzens-Harig, M.; Holte, H. & Thurner, L. et al.​ (2018) 
    Blood, 132(Supplement 1) pp. 781​-781​.​ DOI: https://doi.org/10.1182/blood-2018-99-112403 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​CD31 Expression Determines Redox Status and Chemoresistance in Human Angiosarcomas​
    Venkataramani, V. ; Küffer, S. ; Cheung, K. C.; Jiang, X.; Trümper, L. ; Wulf, G. G.   & Ströbel, P. ​ (2018) 
    Clinical Cancer Research, 24(2) pp. 460​-473​.​ DOI: https://doi.org/10.1158/1078-0432.CCR-17-1778 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Chemotherapy-Based Stem Cell Mobilization Does Not Result in Significant Paraprotein Reduction in Myeloma Patients in the Era of Novel Induction Regimens​
    Oyekunle, A.; Shumilov, E.; Kostrewa, P.; Burchert, A.; Trümper, L. ; Wuchter, P. & Wulf, G.  et al.​ (2018) 
    Biology of Blood and Marrow Transplantation, 24(2) pp. 276​-281​.​ DOI: https://doi.org/10.1016/j.bbmt.2017.10.008 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​In Situ Validation of the Endothelial Cell Receptor GRP78 in a Case of Rhinocerebral Mucormycosis​
    Shumilov, E.; Bacher, U. ; Perske, C. ; Mohr, A. ; Eiffert, H. ; Hasenkamp, J.   & Trümper, L.  et al.​ (2018) 
    Antimicrobial Agents and Chemotherapy, 62(5).​ DOI: https://doi.org/10.1128/AAC.00172-18 
    ​Details  DOI 
  • 2018 | Journal Article | Research Paper
    ​ ​Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes​
    Chapuy, B. ; Stewart, C.; Dunford, A. J.; Kim, J.; Kamburov, A.; Redd, R. A. & Lawrence, M. S. et al.​ (2018) 
    Nature Medicine, 24(5) pp. 679​-690​.​ DOI: https://doi.org/10.1038/s41591-018-0016-8 
    ​Details  DOI 
  • 2018 | Journal Article
    ​ ​Targeted deep sequencing of CD34+ cells from peripheral blood can reproduce bone marrow molecular profile in myelodysplastic syndromes​
    Martin, R.; Acha, P.; Ganster, C.; Palomo, L.; Dierks, S.; Fuster‐Tormo, F. & Mallo, M. et al.​ (2018) 
    American Journal of Hematology, 93(6).​ DOI: https://doi.org/10.1002/ajh.25089 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Oral health status in adult patients with newly diagnosed acute leukemia​
    Busjan, R.; Hasenkamp, J. ; Schmalz, G.; Haak, R.; Trümper, L.   & Ziebolz, D.​ (2017) 
    Clinical Oral Investigations, 22(1) pp. 411​-418​.​ DOI: https://doi.org/10.1007/s00784-017-2127-x 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​TP53 mutation and survival in aggressive B cell lymphoma​
    Zenz, T.; Kreuz, M.; Fuge, M.; Klapper, W.; Horn, H.; Staiger, A. M. & Winter, D. et al.​ (2017) 
    International Journal of Cancer, 141(7) pp. 1381​-1388​.​ DOI: https://doi.org/10.1002/ijc.v141.7 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Clinical Impact of the Cell-of-Origin Classification and the MYC / BCL2 Dual Expresser Status in Diffuse Large B-Cell Lymphoma Treated Within Prospective Clinical Trials of the German High-Grade Non-Hodgkin's Lymphoma Study Group​
    Staiger, A. M.; Ziepert, M.; Horn, H.; Scott, D. W.; Barth, T. F.; Bernd, H.-W. & Feller, A. C. et al.​ (2017) 
    Journal of Clinical Oncology, 35(22) pp. 2515​-2526​.​ DOI: https://doi.org/10.1200/JCO.2016.70.3660 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Anti-infective prophylaxis with aciclovir and cotrimoxazole to reduce the rate of infections and therapy-associated deaths in elderly patients with DLBCL undergoing R-CHOP immunochemotherapy.​
    Murawski, N.; Amam, J.; Altmann, B.; Ziepert, M.; Haenel, M.; Viardot, A. & Neubauer, A. et al.​ (2017) 
    Journal of Clinical Oncology, 35(15_suppl) pp. 7539​-7539​.​ DOI: https://doi.org/10.1200/JCO.2017.35.15_suppl.7539 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Radiotherapy to bulky disease PET-negative after immunochemotherapy in elderly DLBCL patients: Results of a planned interim analysis of the first 187 patients with bulky disease treated in the OPTIMAL>60 study of the DSHNHL.​
    Pfreundschuh, M.; Christofyllakis, K.; Altmann, B.; Ziepert, M.; Haenel, M.; Viardot, A. & Neubauer, A. et al.​ (2017) 
    Journal of Clinical Oncology, 35(15_suppl) pp. 7506​-7506​.​ DOI: https://doi.org/10.1200/JCO.2017.35.15_suppl.7506 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Optimization of rituximab for the treatment of DLBCL: increasing the dose for elderly male patients​
    Pfreundschuh, M.; Murawski, N.; Zeynalova, S.; Ziepert, M.; Loeffler, M.; Hänel, M. & Dierlamm, J. et al.​ (2017) 
    British Journal of Haematology, 179(3) pp. 410​-420​.​ DOI: https://doi.org/10.1111/bjh.14860 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Phase II study of durvalumab (anti-PD-L1 antibody) in combination with R-CHOP or lenalidomide plus R-CHOP in previously untreated, high-risk diffuse large B-cell lymphoma.​
    Nowakowski, G. S.; Kalakonda, N.; Truemper, L. ; Everaus, H.; Fustier, P.; Jaeger, J. & Manzke, O. et al.​ (2017) 
    Journal of Clinical Oncology, 35(15_suppl) pp. TPS7573​-TPS7573​.​ DOI: https://doi.org/10.1200/JCO.2017.35.15_suppl.TPS7573 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial​
    Braulke, F. ; Schulz, X. ; Germing, U.; Schuler, E.; Platzbecker, U.; Nolte, F. & Hofmann, W.-K. et al.​ (2017) 
    Annals of Hematology, 96(6) pp. 887​-894​.​ DOI: https://doi.org/10.1007/s00277-017-2983-0 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​Advanced patient age at diagnosis of diffuse large B-cell lymphoma is associated with molecular characteristics including ABC-subtype and high expression of MYC​
    Paul, U.; Richter, J.; Stuhlmann-Laiesz, C.; Kreuz, M.; Nagel, I.; Horn, H. & Staiger, A. M. et al.​ (2017) 
    Leukemia & Lymphoma, 59(5) pp. 1213​-1221​.​ DOI: https://doi.org/10.1080/10428194.2017.1365851 
    ​Details  DOI 
  • 2017 | Journal Article
    ​ ​WNT5A: a motility-promoting factor in Hodgkin lymphoma​
    Linke, F. ; Zaunig, S. ; Nietert, M. M. ; Bonin, F. von ; Lutz, S. ; Dullin, C.   & Janovská, P. et al.​ (2017) 
    Oncogene, 36(1) pp. 13​-23​.​ DOI: https://doi.org/10.1038/onc.2016.183 
    ​Details  DOI  PMID  PMC 
  • 2017 | Journal Article | Research Paper
    ​ ​Microenvironmental interactions between endothelial and lymphoma cells: a role for the canonical WNT pathway in Hodgkin lymphoma​
    Linke, F.; Harenberg, M.; Nietert, M. M. ; Zaunig, S.; Bonin, F. von ; Arlt, A.   & Szczepanowski, M. et al.​ (2017) 
    Leukemia, 31(2) pp. 361​-372​.​ DOI: https://doi.org/10.1038/leu.2016.232 
    ​Details  DOI  PMID  PMC  WoS 
  • 2016 | Journal Article | Research Paper | 
    ​ ​Partielles Ansprechen auf Crizotinib als Erstlinientherapie bei einem älteren männlichen Patienten mit ROS1-Translokations-positivem Bronchialkarzinom​
    Overbeck, T. R. ; Schmitz, K.; Engelke, C.; Sahlmann, C.-O. ; Hugo, S.; Kellner, L. & Trümper, L.  et al.​ (2016) 
    Karger-Kompass Onkologie, 3(2) pp. 97​-100​.​ DOI: https://doi.org/10.1159/000449192 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Osteolytic lesions occur rarely in patients with B-CLL and may respond well to ibrutinib​
    Shumilov, E.; Wulf, G. ; Ströbel, P. ; Hasenkamp, J. ; Hellige, N.; Bleckmann, A.   & Haase, D.  et al.​ (2016) 
    Leukemia & Lymphoma, 57(10) pp. 2476​-2480​.​ DOI: https://doi.org/10.3109/10428194.2016.1151510 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Partial Response to First-Line Crizotinib in an Elderly Male Patient with ROS1 Translocation-Positive Lung Cancer​
    Overbeck, T. R. ; Schmitz, K.; Engelke, C.; Sahlmann, C.-O. ; Hugo, S.; Kellner, L. & Trümper, L.  et al.​ (2016) 
    Case Reports in Oncology, 9(1) pp. 158​-163​.​ DOI: https://doi.org/10.1159/000444745 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Outcomes Following Lenalidomide for Relapsed/Refractory Mantle Cell Lymphoma Patients at Risk of Bleeding Events Because of Multiple Comorbidities or Treatment: A Post-Hoc Subgroup Analysis of the SPRINT (MCL-002) Trial​
    Trneny, M.; Lamy, T.; Walewski, J.; Belada, D.; Mayer, J.; Radford, J. A & Jurczak, W. et al.​ (2016) 
    Blood, 128(22) pp. 2978​-2978​.​ DOI: https://doi.org/10.1182/blood.V128.22.2978.2978 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Age-dependent analysis of toxicity, mortality, and implementation of an anti-infective prophylaxis in 1171 elderly patients (pts) with aggressive B-cell lymphoma (aNHL): Data from consecutive phase II and III trials of the DSHNHL.​
    Zettl, F.; Ziepert, M.; Altmann, B.; Zeynalova, S.; Loeffler, M.; Schmitz, N. & Pfreundschuh, M. et al.​ (2016) 
    Journal of Clinical Oncology, 34(15_suppl) pp. 7539​-7539​.​ DOI: https://doi.org/10.1200/JCO.2016.34.15_suppl.7539 
    ​Details  DOI 
  • 2016 | Journal Article
    ​ ​Lenalidomide versus investigator's choice in relapsed or refractory mantle cell lymphoma (MCL-002; SPRINT): a phase 2, randomised, multicentre trial​
    Trněný, M.; Lamy, T.; Walewski, J.; Belada, D.; Mayer, J.; Radford, J. & Jurczak, W. et al.​ (2016) 
    The Lancet Oncology, 17(3) pp. 319​-331​.​ DOI: https://doi.org/10.1016/S1470-2045(15)00559-8 
    ​Details  DOI  PMID  PMC  WoS 
  • 2015 | Journal Article | Research Paper
    ​ ​Association of NADPH oxidase polymorphisms with anthracycline-induced cardiotoxicity in the RICOVER-60 trial of patients with aggressive CD20(+) B-cell lymphoma​
    Reichwagen, A.; Ziepert, M.; Kreuz, M.; Gödtel-Armbrust, U.; Rixecker, T.; Poeschel, V. & Toliat, M. R. et al.​ (2015) 
    Pharmacogenomics, 16(4) pp. 361​-372​.​ DOI: https://doi.org/10.2217/PGS.14.179 
    ​Details  DOI  PMID  PMC  WoS 
  • 2014 | Journal Article
    ​ ​Superior vena cava syndrome caused by a malignant tumor: a retrospective single-center analysis of 124 cases​
    Høhloch, K. ; Bertram, N.; Trümper, L. H. ; Beißbarth, T.   & Griesinger, F.​ (2014) 
    Journal of Cancer Research and Clinical Oncology, 140(12) pp. 2129​-2134​.​ DOI: https://doi.org/10.1007/s00432-014-1764-6 
    ​Details  DOI  PMID  PMC  WoS 
  • 2013 | Journal Article
    ​ ​Molecular cytogenetic monitoring from CD34+peripheral blood cells in myelodysplastic syndromes: First results from a prospective multicenter German diagnostic study​
    Braulke, F. ; Jung, K.; Schanz, J.; Götze, K. S.; Müller-Thomas, C.; Platzbecker, U. & Germing, U. et al.​ (2013) 
    Leukemia Research, 37(8) pp. 900​-906​.​ DOI: https://doi.org/10.1016/j.leukres.2013.03.019 
    ​Details  DOI  PMID  PMC  WoS 
  • 2011 | Journal Article
    ​ ​beta-catenin-independent WNT signaling in basal-like breast cancer and brain metastasis​
    Klemm, F. ; Bleckmann, A. ; Siam, L.; Chuang, H.-N.; Rietkoetter, E.; Behme, D.   & Schulz, M. et al.​ (2011) 
    Carcinogenesis, 32(3) pp. 434​-442​.​ DOI: https://doi.org/10.1093/carcin/bgq269 
    ​Details  DOI  PMID  PMC  WoS 
  • 2010 | Journal Article
    ​ ​High-dose therapy followed by autologous stem-cell transplantation with and without rituximab for primary treatment of high-risk diffuse large B-cell lymphoma​
    Glass, B.; Ziepert, M.; Reiser, M.; Freund, M.; Trümper, L. ; Metzner, B. & Feller, A. et al.​ (2010) 
    Annals of Oncology, 21(11) pp. 2255​-2261​.​ DOI: https://doi.org/10.1093/annonc/mdq235 
    ​Details  DOI  PMID  PMC  WoS 
  • 2009 | Journal Article | Research Paper
    ​ ​Characterization of HLA-DR-restricted T-cell epitopes derived from human proteinase 3​
    Piesche, M.; Hildebrandt, Y.; Chapuy, B. ; Wulf, G. G. ; Truemper, L. H.   & Schroers, R.​ (2009) 
    Vaccine, 27(34) pp. 4718​-4723​.​ DOI: https://doi.org/10.1016/j.vaccine.2009.05.010 
    ​Details  DOI  PMID  PMC  WoS 
  • 2009 | Journal Article | 
    ​ ​HSP90 is essential for Jak-STAT signaling in classical Hodgkin Lymphoma cells​
    Schoof, N.; von Bonin, F. ; Truemper, L. H.   & Kube, D.​ (2009) 
    Cell Communication and Signaling, 7 art. 17​.​ DOI: https://doi.org/10.1186/1478-811X-7-17 
    ​Details  DOI  PMID  PMC  WoS 
  • 2005 | Journal Article | Research Paper
    ​ ​NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity​
    Wojnowski, L.; Kulle, B.; Schirmer, M. ; Schlüter, G.; Schmidt, A.; Rosenberger, A.   & Vonhof, S. et al.​ (2005) 
    Circulation, 112(24) pp. 3754​-3762​.​ DOI: https://doi.org/10.1161/CIRCULATIONAHA.105.576850 
    ​Details  DOI  PMID  PMC  WoS 

Publication List

All Articles (Book & Journal) Articles & Preprints Papers (Journal & Conference)

Type

Subtype

Date issued

Author

Peer-Reviewed

Organization

Language

Fulltext

Options

Citation Style

GRO View APA Chicago MLA Vancouver
https://publications.goettingen-research-online.de URI: /cris/rp/rp34513
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
ASC DESC
Title
ASC DESC

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items (max. 800 for CSV/Excel) from the publications list, then choose an export format below.